A Phase I Study of Romidepsin in Combination With Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed or Refractory Aggressive Lymphomas Enriched for T-Cell Lymphomas.

A Phase I Study of Romidepsin in Combination With Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed or Refractory Aggressive Lymphomas Enriched for T-Cell Lymphomas. Clin Lymphoma Myeloma Leuk. 2025 May; 25(5):328-336.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Deoxycytidine
Depsipeptides
Dexamethasone
Drug Resistance, Neoplasm
Female
Humans
Lymphoma, T-Cell
Male
Maximum Tolerated Dose
Middle Aged
Neoplasm Recurrence, Local
Treatment Outcome

authors with profiles

Peter Riedell